Metabotropic Glutamate Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice.

There is substantial evidence that glutamate can modulate the effects of 5-hydroxytryptamine (5-HT) receptor activation through stimulation of metabotropic glutamate (mGlu) receptors in the prefrontal cortex. Here we show that constitutive deletion of the mGlu gene profoundly attenuates an effect of 5-HT receptor activation using the mouse head twitch response (HTR). MGlu and mGlu receptor knockout (KO) as well as age-matched ICR (CD-1) wild type (WT) mice were administered (±)1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and observed for head twitch activity. DOI failed to produce significant head twitches in mGlu receptor KO mice at a dose 10-fold higher than the peak effective dose in WT or mGlu receptor KO mice. In addition, the mGlu receptor agonist LY379268, and the mGlu receptor positive allosteric modulator (PAM) CBiPES, potently blocked the HTR to DOI in WT and mGlu receptor KO mice. Conversely, the mGlu receptor antagonist LY341495 (10 mg/kg) increased the HTR produced by DOI (3 mg/kg) in mGlu receptor KO mice. Finally, the mGlu receptor potentiator CBiPES was able to attenuate the increase in the HTR produced by LY341495 in mGlu receptor KO mice. Taken together, all of these results are consistent with the hypothesis that that DOI-induced head twitches are modulated by mGlu receptor activation. These results also are in keeping with a critical autoreceptor function for mGlu receptors in the prefrontal cortex with differential effects of acute vs. chronic perturbation (e.g., constitutive mGlu receptor KO mice). The robust attenuation of DOI-induced head twitches in the mGlu receptor KO mice appears to reflect the critical role of glutamate in ongoing regulation of 5-HT receptors in the prefrontal cortex. Future experiments with inducible knockouts for the mGlu receptor and/or selective mGlu receptor agonists/PAMs/antagonists could provide an important tools in understanding glutamatergic modulation of prefrontal cortical 5-HT receptor function.